Pelvic Inflammatory Disease clinical trials
The registry lists 34 studies for Pelvic Inflammatory Disease across more than 10 countries. 4 are recruiting or about to start. 23 of them are mainly about Pelvic Inflammatory Disease (how this is decided). Per ClinicalTrials.gov, last updated 2026-08-19. Counting its narrower condition Endometritis too: 84 studies, 15 open.
Get an email when these change. Save the Pelvic Inflammatory Disease studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Bayer (3) · Pfizer (3) · Johns Hopkins University (2) · China Academy of Chinese Medical Sciences (2) · Jiangsu Hansoh Pharmaceutical Co., Ltd. (1) · Unity Health Toronto (1) · Sharon Hillier (1) · Children's Hospital of Philadelphia (1)
What is being tested here
Drugs under test in Pelvic Inflammatory Disease studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Moxifloxacin | 0 | 2 | 3 |
| Metronidazole | 0 | 1 | 2 |
| Drugs, Chinese Herbal | 0 | 0 | 1 |
| Zabedosertib | 0 | 0 | 1 |
| Ceftriaxone | 0 | 1 | 1 |
| Azithromycin | 0 | 1 | 1 |
| Doxycycline | 0 | 0 | 1 |
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The study
- Dec 2026Technology Based Community Health Nursing(TECH-N) to Prevent Recurrent STIs After PID II · Johns Hopkins University
Who these studies take
Of the 4 Pelvic Inflammatory Disease studies recruiting now, 3 (75%) set no upper age limit and 1 (25%) stop at 75 or younger. 0 (0%) take children under 18. 4 (100%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 0 (0%) | 0 (0%) |
| 18 | 3 (75%) | 0 (0%) |
| 30 | 4 (100%) | 0 (0%) |
| 40 | 4 (100%) | 0 (0%) |
| 50 | 4 (100%) | 0 (0%) |
| 65 | 3 (75%) | 0 (0%) |
| 75 | 3 (75%) | 0 (0%) |
| 85 | 3 (75%) | 0 (0%) |
Across all 34 studies, recruiting or not: 56% stop at 75 or younger and 56% at 65; 41% take children; 91% are for women only and 3% for men only; 26% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 34 of 34. search them.
- Comparison of Proton or Intensity Modulated Radiation Therapy After Surgery for Endometrial or Cervical CancerRecruitingNCT04567771Not applicable1 country
- Assessing the Mechanisms and Impact of a Novel Cannabinoid Product for Gynecologic PainRecruitingNCT07728695Phase 1/21 country
- Clinical Trial of Acupoint Application in Improving the Sequelae of Pelvic Inflammatory Disease and Chronic Pelvic PainRecruitingNCT06360965Not applicable1 country
- Pilot Study Evaluating Outpatient Management of Tubo-ovarian AbscessesRecruitingNCT054086241 country
- Technology Based Community Health Nursing(TECH-N) to Prevent Recurrent STIs After PID IIActive, not recruitingNCT03828994Not applicable1 country
- Effect of an Anti-inflammatory Diet on Patients With Cervical CancerCompletedNCT03994055Not applicable1 country
- Enriched Environments in EndometriosisCompletedNCT04179149Not applicable1 country
- The Diagnostic Utility of Ultrasound in Pelvic Inflammatory Disease (PID)Active, not recruitingNCT067565681 country
- Rate of Pelvic Inflammatory Disease at St. Michael's HospitalCompletedNCT007834191 country
- Efficacy and Safety of Fuke Qianjin Capsule in Patients With Pelvic Inflammatory DiseasesCompletedNCT04723069Phase 21 country
- Prevention of Diseases Induced by Chlamydia TrachomatisCompletedNCT02904811Not applicable1 country
- Pelvic Inflammatory Disease in COVID-19 EraStatus unknownNCT056487471 country
- MOCHI: An RCT of Mindfulness as Treatment for Chronic Pelvic Pain in AD WomenCompletedNCT04104542Not applicable1 country
- Effect of Prophylactic Antibiotics for Hysterosalpingography on Post Procedure MorbidityStatus unknownNCT04234945Not applicable1 country
- Technology Enhanced Community Health Nursing (TECH-N) StudyCompletedNCT01640379Not applicable1 country
- A Clinical Study on Qianjin Capsule of Gynaecology Combined With Antibiotics for Pelvic Inflammatory Diseases (Damp-heat Stasis and Qi Deficiency Syndrome)Status unknownNCT04031664Phase 4
- A Clinical Study on Kangfu Anti-inflammatory Suppository of Gynaecology Combined With Antibiotics for Pelvic Inflammatory Diseases (Evidence of Dampness and Heat Accumulation)Status unknownNCT04035785Phase 4
- Database of Pelvic Inflammatory DiseaseStatus unknownNCT025678121 country
- First in Human Study to Investigate the Safety, Tolerability, Pharmacokinetics and to Explore Pharmacodynamics of BAY1834845CompletedNCT03054402Phase 11 country
- The Importance of Anti-anaerobic Therapy for Acute Pelvic Inflammatory Disease (PID)CompletedNCT01160640Phase 21 country
- A Trial to Assess the Efficacy and Safety of Morinidazole in Women With Pelvic Inflammatory DiseaseStatus unknownNCT03391440Phase 41 country
- Surgical Success After Laparoscopic vs Abdominal HysterectomyCompletedNCT01793584Not applicable1 country
- Drug Use Investigation Of Azithromycin IV For Pneumonia Or Pelvic Inflammatory Disease (Regulatory Post Marketing Commitment Plan)CompletedNCT01671280
- Clinical Research of TCM on Pelvic Inflammatory Disease SequelaeStatus unknownNCT02972151Phase 21 country
- The Role of Novel Organisms in Acute EndometritisCompletedNCT012361311 country
- Immunopathogenesis of ChlamydiaCompletedNCT006076591 country
- Community-Based Trial of Screening for Chlamydia Trachomatis to Prevent Pelvic Inflammatory DiseaseCompletedNCT00115388Not applicable1 country
- Improving Primary Care Follow-up for Patients With Pelvic Inflammatory DiseaseCompletedNCT01299259Not applicable1 country
- Uncomplicated Pelvic Inflammatory Disease. Treatment With Moxifloxacin.CompletedNCT00683865Phase 313 countries
- A Trial Comparing Moxifloxacin Versus Levofloxacin Plus Metronidazole In Uncomplicated Pelvic Inflammatory DiseaseCompletedNCT00453349Phase 37 countries
- A Phase 3 Study Of Intravenous Metronidazole For Intrabdominal InfectionCompletedNCT01473836Phase 31 country
- Moxifloxacin Versus Ofloxacin Plus Metronidazole in Uncomplicated Pelvic Inflammatory Disease: Multicenter Randomized Controlled TrialsCompletedNCT01799356Phase 41 country
- Study Of Azithromycin Intravenous Formulation Against Pelvic Inflammatory Disease (PID) In JapanCompletedNCT00871494Phase 31 country
- To Compare Ofloxacin With Azitromycin for Pelvic Inflammatory Disease (PID) TreatmentCompletedNCT01241110Phase 41 country